Dr Thomas Werner

Senior Independent Non-Executive Director and
Chairman of the Remuneration Committee

Thomas Werner was appointed to the Board as a Non-Executive Director in May 2009. He is Chairman of the Remuneration Committee and is a member of the Audit and Nomination & Governance Committees.

Thomas Werner has over 30 years of experience in the pharmaceutical industry, previously as Senior Vice-President of GlaxoSmithKline where he was managing Director for Germany and also co-ordinated their European oncology business. Prior to that, he was responsible for Glaxo Wellcome Germany and Central Europe, Bristol-Myers Squibb Germany and Convatec Germany/Central Europe. Dr Werner sits on the Boards of Basilea Pharmaceutica Ltd, Riemser Pharma GmbH, BSN Medical and Blackfield AG. He is Chairman of the investor advisory committee of Seventure (France) Health for Life capital investment fund. Beside his business responsibilities he has previously served for many years on the board of trustees of the Paul Ehrlich Foundation and the Robert Koch Foundation and was a Director of the American Chamber of Commerce in Germany representing healthcare companies. He is a German citizen and holds a degree in Chemistry from the University of Göttingen.

Dr Thomas Werner Dr Thomas Werner

> Board of directors

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.